Ramsay Health Care Limited (RHC) Fair Value & Analysis
Healthcare · AU · Market cap A$10.0B
Fair value as of: Aug 13, 2026
From 24 valuation models · updated today
Fair value updated Aug 13, 2026, revised from A$3.43 to A$69.84 (+1,936.2%) since Jul 19, 2026. Share price +4.4% over the past month.
Below-average quality, screening 56% undervalued on our models.
What matters now
- The model range is unusually wide (A$34.10 to A$105.58). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (46/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range A$30.31 – A$78.21 · fair‑value band A$34.10 – A$105.58 · the A$44.89 price screens below the A$69.84 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Ramsay Health Care Limited (RHC) currently trades at A$44.89, while our model-based Fair Value estimate is A$69.84, implying the stock looks roughly 55.6% undervalued today. The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Ramsay Health Care Limited generated revenue of A$18.6B at a net margin of 1.6%. Revenue grew 9.7% year over year. It earns a return on equity of 5.1%. Net debt stands at A$11.4B. Fundamentals as of Aug 13, 2026
Our scenario range runs from A$34.10 (bear case) to A$105.58 (bull case); at A$44.89, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 49% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 56%, RHC screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (A$89.52) versus Earnings-Based (A$1.31). Highest evidence: Growth DCF (80).
Notify me when RHC reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 44 · Market factors (momentum, volatility) 72
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Ramsay Health Care Limited owns and operates hospitals in Australia and internationally. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ramsay Health Care Limited reported revenue of A$17.8B in FY2025 versus A$12.9B in FY2021, a compound +8.4%/yr. Reported net income was A$24.0M in FY2025, compounding −51.9%/yr from FY2021.
of which total revenue +10.1 pp · buybacks/dilution −1.5 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch RHC: get an alert when its fair value changes →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- RAMSAY SANTE : Press Release - Refinancing new steps forward
- RAMSAY SANTE launches senior debt refinancing
- Craig Drummond Buys Handful Of Shares In Ramsay Health Care
- Ramsay Health Care Ltd (RMYHY) (Half Year 2026) Earnings Call Highlights: Strong Australian ...
Peer Group
Medical Care Facilities · 265 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare Ramsay Health Care Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ramsay Health Care Limited (RHC) overvalued or undervalued?
What is the fair value of RHC?
What is the quality score of RHC?
What is the revenue of Ramsay Health Care Limited (RHC)?
What is the net profit margin of RHC?
Does Ramsay Health Care Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Ramsay Health Care Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.